Clinical Risk Factors and Evaluation Framework Before starting any GLP-1 medication, your provider should assess personal history of pancreatitis, inflammatory bowel disease, severe gastroparesis, chronic diarrhea, and family history of medullary thyroid carcinoma
Additional benefits have been observed in renal outcomes , with some GLP-1 agonists showing protective effects, primarily through reductions in albuminuria and a slower decline in estimated glomerular filtration rate (eGFR)
Cherta-Murillo A, Lett AM, Frampton J, Chambers ES, Finnigan TJA, Frost GS
253 These limitations stem from the pleiotropic nature of upstream signaling pathways and their network-level crosstalk, which diminishes the efficacy of monotherapeutic approaches targeting cardiac remodeling
Together, they work synergistically to increase natural growth hormone levels, promoting significant health benefits